ScreenerHero
BLLNBillionToOne Inc. Class A Common Stock
NAS · US · Healthcare · Diagnostics & Research · billiontoone.com
94.87USD+3.49%Mkt Cap: 4.33B $P/E: 129.11

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the sing…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DAP
Danaher Corporation
$142.58BUSDP/E 38.5
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group AG
$47.21BUSDP/E 38.3
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILU
Illumina, Inc.
$30.40BUSDP/E 40.4
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMérieux S.A.
$9.55BUSDP/E 19.1

Key Statistics

Company
Market Cap4.33B $
Enterprise Value4.09B $
Revenue (TTM)397.41M $
Gross Profit208.46M $
Net Income (TTM)7.45M $
Revenue/Share11.76 USD
Last Price94.87 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees713
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)129.11
P/E (Forward)71.63
PEG—
EV/EBITDA81.43
EV/Revenue10.29
P/S11.31
P/B8.31
EPS (TTM)0.74
EPS (Forward)1.33
52W Range
61.9637% of range150.44
52W High150.44 USD
52W Low61.96 USD
Profitability
Gross Margin68.32%
Oper. Margin5.03%
EBITDA Margin12.64%
Profit Margin2.44%
ROE1.55%
ROA1.18%
Growth
Revenue Growth64.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF24.59M $
CapEx (TTM)8.92M $
FCF Margin3.03%
FCF Yield0.28%
Net Debt-404.71M $
Net Debt/EBITDA-8.06
Balance Sheet
Debt/Equity0.23
Current Ratio11.69
Quick Ratio11.19
Book Value/Sh11.46 USD
Cash/Share11.63 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)119.71 USD
Upside (mean)+26.2%
Target Range90.00 USD – 145.00 USD
$90.00+26.2% to mean$145.00
# Analysts7
Ownership
Shares Out.42.64M
Float25.31M
Insiders37.06%
Institutions45.21%
Short Interest
Short Ratio3.1d
Short % Float7.45%
Short % Out.4.10%
Shares Short1.92M
Short (prev mo.)2.42M
Technical
SMA 50115.36 (-17.8%)
SMA 20095.34 (-0.5%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)753.49K
Avg Vol (10d)706.41K
Technical Indicators
RSI (14)34.5
MACD-8.0049
MACD Signal-3.9109
MACD Hist.-4.0940
BB Upper159.64 USD
BB Middle116.91 USD
BB Lower74.18 USD
BB Width73.10%
ATR (14)8.303 USD
Vol Ratio (20d)0.66x